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ABSTRACT

A blood oxygenator includes an integral pneumatic pump
disposed substantially Within a housing thereof, an inlet blood
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EVEN PERFUSION PUMP-INTEGRATED
BLOOD OXYGENATOR

tageous in situations requiring peripheral cannulation, since
the cannula size is strictly limited by the size of the blood
vessel to be cannulated.

To solve this and other problems, the present disclosure
provides a compact hollow ?ber membrane blood oxygenator
including an integral pneumatic pump and blood ?ow redi
rector structures, eliminating the need for a separate pump
and so simplifying the arti?cial lung circuit. The present
disclosure also provides such an oxygenator including an
additional pneumatic pump serving as an atrium, to the oxy

This application claims the bene?t of priority in Us. Pro
visional Patent Application Ser. Nos. 61/522,411 ?led on

Aug. 11, 2011 and 61/651,164 ?led on May 24, 2012, the
entirety of the disclosures of each of which are incorporated

herein by reference.
TECHNICAL FIELD

genator pump inlet, allowing withdrawal from and pumping
blood to a patient to occur simultaneously, increasing e?i

The present invention relates generally to the ?eld ofmedi

ciency of the arti?cial lung circuit and the infusion/drainage

cal devices. In particular, the invention relates to a pump

cannulae, and allowing use of cannulae having a reduced
inner diameter compared to conventional cannulae. The
device of the present disclosure provides an even blood ?ow
pattern, preventing or reducing incidence of thrombosis. In

integrated blood oxygenator for use in arti?cial lung (AL)

applications.
BACKGROUND OF THE INVENTION

turn, the presently disclosed design simpli?es the blood cir
cuit and also provides a pulsatile blood ?ow pattern, promot
ing active blood mixing and thereby improving gas exchange

Conventional arti?cial lung/gas exchanger/oxygenators
include at least a body, often de?ning a cylinder, a blood inlet,
one or more blood outlets, and a gas (oxygen) supply inlet and
outlet. The interior of such devices includes a plurality of
hollow membrane ?bers whose porosity allows passage of
gases such as oxygen and C02, but not of liquid, blood cells,
blood proteins, etc. Gas in?ow/out?ow ports are provided,
typically in ?uid communication with one another via the
lumens of the hollow membrane ?bers, Using one or more

within the pump. The present device ?nds use at least in
treatment of acute or chronic lung failure, as well as for

combined right heart and lung (RVAD) failure.
25

The present disclosure provides a blood oxygenator for use
as an arti?cial lung, in RVAD, and the like. The oxygenator

pumps or potentially the patient’s own heart pumping action,

blood ?ow is established whereby oxygen-depleted and C02

30

enriched blood is removed from a patient’s bloodstream,
passes into the device via the blood inlet, passes over exterior
surfaces of the hollow membrane ?bers, and exits the device

through the blood outlet. During this traversal, oxygen passes
from the hollow ?ber lumens into the blood, and CO2 is

lungs,” for their ability to replace or supplement the gas
exchange function of the patient’s own lungs.
Disadvantageously, conventional arti?cial lungs often pro
vide uneven blood perfusion. This is because existing such
devices typically include areas wherein blood ?ow becomes

provided, which in combination with the integral pneumatic
of stagnation.
35

In an embodiment, an atrium is provided at an inlet of the

blood oxygenator. The atrium is de?ned by an additional
pneumatic pump for promoting blood withdrawal from a

patient body into the oxygenator by establishing a negative
blood pressure. In this embodiment, the oxygenator pump
40

described above functions substantially as a ventricle. The

atrium pump and oxygenator pump are separately driven.

During the bulk of the pumping cycle (for example, 80-95%),
45

lessened or even stagnant. This causes thrombosis and in
extreme cases device failure. In turn, a traditional arti?cial

a positive pressure is applied to the oxygenator pump (ven
tricle) to push blood into the patient via an infusion cannula
and a simultaneous small negative pressure applied to the
atrium withdraws blood from the patient via a drainage can

nula. For the remainder of the pumping cycle (in the example,
5-20%), a negative pressure is applied to the oxygenator

lung circuit consists of an oxygenator/arti?cial lung as
described for gas exchange/oxygenation, a double lumen can
nula or two separate cannulas for blood infusion/drainage
into/from a patient, and a blood pump to drive the blood

includes an integral pneumatic pump enclosed substantially
within a housing thereof, providing a compact and ef?cient
design. Inlet blood redirectors and outlet blood collectors are
pump promote an even perfusion of blood, eliminating areas

removed from the blood and passes into the hollow ?ber
lumens to be removed by a sweep gas. From there, the oxy
genated blood is returned to the patients bloodstream. It is for
that reason that such devices are often termed “arti?cial

SUMMARY OF THE INVENTION

50

pump (ventricle) and zero pressure is applied to the atrium,
moving blood rapidly from the atrium to the ventricle By
cyclically maintaining an internal pressure of the atrium

through the circuit. In a typical pneumatically driven pump,

pneumatic pump(s) at zero or less, a constant, even supply of

each pumping cycle includes a systolic phase (pushing blood

blood from the patient is provided at the blood oxygenator

from a pump blood chamber into a patient through an infusion

cannula lumen) and a diastolic phrase (withdrawing blood
from the patient into the pump blood chamber through a

drainage cannula lumen). The systolic and diastolic phases of
the pumping cycle are performed alternately, not simulta
neously. Therefore, the infusion/drainage cannulae can only
move blood during 50% of the pumping cycle. This requires

55

inlet, thereby eliminating the pulsatile inlet blood ?ow pat
terns provided by conventional pumping systems.
In turn, a blood oxygenating system employing the blood
oxygenator of the present disclosure is described, for remov
ing blood from a patient body and returning blood to same.

These and other embodiments, aspects, advantages, and
60

features of the present invention will be set forth in the

twice the blood ?ow rate and twice the driven pressure/ delta

description which follows, and in part will become apparent

p to move the same amount of blood compared to a pump

to those of ordinary skill in the art by reference to the follow

cycle where the systolic and diastolic phases could be per
formed simultaneously. For this reason, a relatively larger

ing description of the invention and referenced drawings or by
practice of the invention. The aspects, advantages, and fea

sized cannula is needed to move the same amount of blood as 65 tures of the invention are realized and attained by means of the

would be possible if the cannulae could move blood for a

instrumentalities, procedures, and combinations particularly

greater percentage of the pumping cycle, which is disadvan

pointed out in the appended claims. Unless otherwise indi

US 8,906,300 B2
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cated, any references discussed herein are speci?cally incor

blood passes through the oxygenator 10. An inlet blood ?ow
redirector 28 is provided at an end of the oxygenator 10 distal
from the blood inlet 14 for evenly redirecting blood ?ow
passing through the blood inlet 14. In an embodiment, a

porated by reference in their entirety into the present disclo
sure.

frusto-conical inlet blood ?ow redirector 28 is provided at a
distal end of the blood inlet 14 (see FIG. 3), secured to or

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings incorporated in and forming

molded with the distal end of the blood inlet 14 by one or more
columns 30. At least a portion of the conical inlet blood ?ow
redirector 28 is disposed in an interior of the blood inlet 14
distal end. Like structures are described in copending US.

a part of the speci?cation, illustrate several aspects of the
present invention, and together with the description serve to

explain the principles of the invention. In the drawings:

Published Patent Appl. No. 2013/0211483, ?led concurrently
herewith and incorporated herein in its entirety by reference.

FIG. 1 shows a housing for the oxygenator of the present

disclosure;

As shown in FIG. 2, the inlet blood ?ow redirector 28

FIG. 2 shows a cross-sectional side view of the oxygenator;
FIG. 3 shows an inlet blood ?ow redirector for the oxygen

promotes even radial perfusion across a surface of the inlet
potting 24 at a bottom of the oxygenator and also even axial

ator;
FIG. 4 graphically shows blood ?ow through the present
oxygenator (right ?gure) versus a conventional oxygenator

blood ?ow as blood travels through the oxygenator 10

towards the blood outlet 16 (see arrows), eliminating stagnant

(left ?gure);
FIG. 5 shows graphically shows blood ?ow pressure con
tours for the present oxygenator (right ?gure) versus a con

blood ?ow in the oxygenator 10.
In turn, a blood collection channel 32 is provided at atop of
20

the oxygenator 10, whereby blood exiting the membrane
array 22 is collected and redirected to the blood outlet 16 (see

ventional oxygenator (left ?gure);

FIG. 6). A substantially crescent-shaped blood collection

FIG. 6 shows a top view of the oxygenator of the disclo

channel 32 is shown, although the skilled artisan will appre

sure;

ciate that other cross-sectional shapes are possible and con

FIG. 7 shows a cross-sectional side view of the oxygenator,

including an integrated pneumatic pump;
FIG. 8 shows the oxygenator of FIG. 7 in systolic phase;

25

FIG. 9 shows the oxygenator of FIG. 7 in diastolic phase;
FIGS. 10a and 10b show the oxygenator including an

atrium, in diastolic phase (FIG. 10a) and in systolic phase
(FIG. 10b); and

30

templated, such as segmental, triangular, etc. The blood col
lection channel 32 regulates blood ?ow evenly at the outlet
end of the oxygenator 10, and further guides blood to the
blood outlet 16. That is, blood enters via the blood inlet 14 and
is evenly redirected by the inlet blood ?ow redirector 28 as
summarized above to pass over the hollow ?ber membrane

array 22. On exiting the membrane array 22, bloodpasses into
the blood collection channel 32 and therefrom exits the oxy

FIG. 11 graphically presents relative internal pressures of

the atrium and oxygenator in systolic and diastolic phases.

genator 10 via the blood outlet 16. In that manner, areas of
DETAILED DESCRIPTION OF THE
ILLUSTRATED EMBODIMENTS

stagnant blood ?ow at or near the blood outlet 16 are reduced
35 or eliminated.

Rather than utiliZing an external pump as is common with

In the following detailed description of the illustrated
embodiments, reference is made to the accompanying draw
ings that form a part hereof, and in which is shown by way of
illustration, speci?c embodiments in which the invention may

conventional oxygenators, the oxygenator 10 of the present
disclosure includes an integral pneumatic pump to provide
pumping action for passing blood from the blood inlet 14,
40

be practiced. These embodiments are described in su?icient
detail to enable those skilled in the art to practice the inven
tion. Also, it is to be understood that other embodiments may
be utilized and that process, reagent, software, and/or other

changes may be made without departing from the scope of the
present invention.

45

of pump and oxygenator is provided. Providing further
advantages, the integral pneumatic pump provides a pulsatile
blood ?ow pattern, promoting active blood mixing for
improved gas exchange performance and an improved blood
?ow pattern to reduce thrombogenicity. Because of that

improved gas exchange performance, it is possible to provide

In one aspect, the present disclosure provides a blood oxy

genator 10 (see FIG. 1) including a housing 12, at least one
blood inlet 14. and at least one blood outlet 16. At least one
sweep gas inlet 18 and at least one sweep gas outlet 20 are

over the hollow membrane array 22, and to the blood outlet
16. As such, a compact, economical and ef?cient combination

50

a lesser gas exchange surface area compared to conventional
oxygenators, allowing a more compact unit.
With reference to FIG. 7, a cylinder 34 is disposed in an

provided for supplying a gas to and removing same from the

interior of the hollow membrane array 22. Within cylinder 34,

oxygenator 10, typically with the sweep gas being passed

a ?exible membrane 36 is disposed to de?ne a pneumatic
pump 38. Pump inlet and outlet valves 40, 42, in an embodi

through the oxygenator 10 in a direction opposite that of the
blood ?ow. For as exchange, a hollow ?ber membrane array
22 is provided, using membranes as are known in the art.

Arrays 22 of membranes may be provided arranged substan
tially parallel to a longitudinal axis of the oxygenator 10
housing 12, or alternatively diagonal spirally wound mem
brane arrays 22 (FIG. 2) may be provided. Each such structure
is well known in the art. Inlet potting 24 and outlet potting 26
are provided and disposed to prevent entry of blood into the

55

pump 38 (see arrows).
A pump gas inlet/outlet 44 is connected to a pneumatic

60

lumens of the hollow ?bers of the membrane arrays 22, also as
are known in the art. The inlet potting 24 may de?ne an

inverted dome shape, further assisting in promoting even
redistribution of blood passing through the oxygenator 10.
The system 10 of the invention further includes blood ?ow
redirector structures, providing an even blood ?ow pattern as

ment being duck-bill valves of known con?guration, prevent
other than a uni -directional blood ?ow through the pneumatic

65

console (not shown) for providing gas to operate the pneu
matic pump 38. Pump gas is cyclically supplied to and with
drawn from the pump gas inlet outlet 44, causing the ?exible
membrane 36 to expand and contract, providing a pumping
action to promote blood ?ow. As shown in FIGS. 8 and 9,
when gas is supplied to the pump gas inlet outlet 44 (systole),
the ?exible membrane 36 collapses, closing the pump inlet
valve 40 and forcing blood out of the pneumatic pump 38 via
the now open outlet valve 42 to perfuse through the hollow
membrane ?ber array 22. When gas is withdrawn from the

US 8,906,300 B2
5
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pump gas inlet/outlet 44 (diastole), the ?exible membrane 36

cannula such as those described in Us. Pat. No. 7,473,239
and/or U.S. Published Patent Appl. No. US 2011/0040241 is

expands, closing the pump outlet valve 42 and opening the
pump inlet valve 40, generating negative pressure and draw
ing blood into the pneumatic pump 38 from the patient’ s body
through the now-open pump inlet valve 40. On the next cycle,

preferred, which both passes blood from a patient’s body via
a withdrawal cannula into the oxygenator 10 andpasses blood
back into the patient’s body via a delivery cannula. This has
the further advantage of reducing the length of the de?ned
blood ?ow circuit, and eliminates multiple and potentially

the blood is delivered from the pneumatic pump 38 as
described above.
In another aspect, an atrium 100 is provided which further

dangerous (to the patient) cannulations.
There is accordingly provided by the present disclosure an
oxygenator 10 which provides a pulsatile, evenly dispersed
blood ?ow therethrough, augmenting gas exchange perfor

improves pump performance and blood ?ow through the oxy
genator 10 of the present disclosure (see FIGS. 10a and 10b).
In an embodiment, the atrium 100 is de?ned by at least one

additional pneumatic pump 102, disposed at or de?ning the

mance and in turn allowing a lessened gas exchange surface
area. The oxygenator 10 may include an atrium 100 de?ned
by one or more additional pneumatic pumps 102, for regulat
ing and providing an even blood supply from a patients’

blood inlet of the oxygenator 10. As shown, the at least one

additional pneumatic pump 102 is con?gured substantially as
described above for the integral pneumatic pump 38 of the
oxygenator 10, including a pneumatic cylinder 104 and ?ex

entirely separate.

circulatory system into the oxygenator 10. The oxygenator 10
?nds use in a variety of procedures, including arti?cial lung
applications and RVAD applications. Unlike conventional
oxygenator designs, the present oxygenator 10 reduces or
eliminates regions of stagnant or limited blood ?ow leading to
thrombosis and device occlusion failure, and further provides

The atrium 100 operates in systolic and diastolic phases as
described for the oxygenator 10 pneumatic pump 38. That is,

reduces thrombogenicity.

ible membrane 106, and a gas inlet/outlet 108. For conve

nience and compactness, the atrium outlet valve may de?ne

the inlet valve 40 for the oxygenator 10 integrated pneumatic
pump 38, although of course the valve structures may be

cyclically supplying gas to the gas inlet/outlet 108 causes the
atrium pneumatic pump 102 ?exible membrane 106 to

20

a pulsatile ?ow which also decreases stagnant blood ?ow and

In turn, the integrated pump design of the oxygenator 10
25

expand and collapse, passing blood through the pneumatic
pump 102 and into the oxygenator 10.
In use, the atrium 100 is kept primarily in a state of negative
internal pressure by withdrawal of gas, with the exception of
a time immediately prior to the diastolic phase of the oxygen

ator 10 pneumatic pump 38 (see FIG. 11). Typically, the
atrium 100 internal pressure is substantially zero at the high
est, i.e. during diastole. This is accomplished by intermit
tently discontinuing withdrawal of gas from the atrium 100
(as distinguished from af?rmatively supplying gas to the
atrium 100 pneumatic pump 102). In contrast, the oxygenator
10 pneumatic pump 38 is provided only a very short phase of
negative internal pump pressure (see FIG. 11). In diastole,
when an internal pres sure of the atrium 100 pneumatic pump
102 is highest, an internal pressure of the oxygenator 10

comfort and mobility, and which also reduces risk of compli
cating factors such as sepsis and the like resulting from

replacing the devices repeatedly. The combined integrated
pump/ arti?cial lung design simpli?es the PAL circuit in that
30

only one component is provided in the circuit, and further
increases pump ef?ciency by eliminating blood ?ow resis
tance from connections between the pump and the arti?cial

lung.
35

One of ordinary skill in the art will recognize that addi
tional embodiments of the invention are also possible without

departing from the teachings herein. This detailed descrip
tion, and particularly the speci?c details of the exemplary
embodiments, is given primarily for clarity of understanding,
40

pneumatic pump 38 is made slightly negative by withdrawal
of gas (see FIG. 11).

and no unnecessary limitations are to be imported, for modi
?cations will become obvious to those skilled in the art upon

reading this disclosure and may be made without departing
from the spirit or scope of the invention. Relatively apparent
modi?cations, of course, include combining the various fea

By this design, the skilled artisan will appreciate that a
consistent ?ow of blood is established into the inlet of the

oxygenator 1 0 compared to the pulsatile and irregular entry of
blood into oxygenators established by conventional designs.

provides a compact, ef?cient design which improves patient
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tures of one or more ?gures or examples with the features of
one or more of other ?gures or examples.

What is claimed is:

This is because the internal pressure of the atrium 100 into

1. A blood oxygenator, comprising:

which blood ?rst ?ows is almost always negative and blood is
almost always draining from the patient and into the atrium.
In turn, very little resistance is imposed to transfer of blood

a housing, a blood inlet, a blood outlet, a sweep gas inlet,
and a sweep gas outlet;
a hollow membrane ?ber array disposed within an interior
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of the housing for gas exchange to and from blood pass

from the atrium 100 into the oxygenator 10 to ?ll the pneu
matic pump 38, since when pump gas is withdrawn from the
oxygenator 10 pneumatic pump 38 (diastole, see FIGS. 10a
and 11), the internal pressure of the atrium 100 is zero at its

highest, i.e. slightly higher than the internal pressure of the
oxygenator 10 pneumatic pump 38. By this mechanism,

ing through the oxygenator;
55

an inlet blood ?ow redirector for evenly dispersing blood
passing through the blood inlet through a distal end of
the oxygenator, the inlet blood ?ow redirector including
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end of the blood inlet;
an outlet blood ?ow collector for collecting blood exiting
the hollow membrane array prior to exiting the oxygen
ator via the blood outlet; and

a conical tip extending into an interior lumen of a distal

transfer of blood from the atrium 100 to the oxygenator 10

pneumatic pump 38 is promoted by that slight pressure dif
ferential. These differentials are shown graphically in FIG.
11. Of course, the more even and non-pulsatile blood ?ow
pattern established between the atrium 100 and the oxygen
ator 10 achieved by the present mechanism should not be

confused with the pulsatile ?ow established forblood passing
through the oxygenator 10 via the oxygenator pneumatic
pump 38, for the bene?ts described above.

The present oxygenator 10 will typically be supplied with
blood from a patient’s body by a cannula. A dual lumen

an integrated pneumatic pump disposed substantially
within a perimeter de?ned by the housing, further
wherein the integrated pneumatic pump is disposed in an
interior of the hollow ?ber membrane array.
2. The oxygenator of claim 1, wherein the inlet blood ?ow
redirector de?nes a substantially frusto-conical shape and is
disposed at an end of the housing distal to the blood inlet.

US 8,906,300 B2
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8. A blood oxygenator, comprising:

3. The oxygenator of claim 1, wherein the outlet blood
collector de?nes a channel for guiding blood to the blood
outlet.
4. The oxygenator of claim 1, wherein the oxygenator

pneumatic pump is de?ned by a cylinder centrally disposed
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within the hollow membrane ?ber array and further including

of the housing for gas exchange to and from blood pass

an interior ?exible membrane and one or more valves for

ing through the oxygenator; and
an integrated pneumatic pump disposed substantially

establishing a unidirectional blood ?ow by way of a cyclical
supply of a pump gas.
5. The oxygenator of claim 4, wherein the valves are uni

within a perimeter de?ned by the housing, further
wherein the integrated pneumatic pump is disposed in an

directional valves disposed at an entry and at an exit of the
?exible membrane for maintaining a unidirectional blood
?ow.

6. The oxygenator of claim 1, further including another
pneumatic pump provided in an atrium disposed at the blood
inlet.
7. The oxygenator of claim 6, further including an atrium
cyclical gas supply which maintains the atrium at an internal
pressure of up to zero.

a housing, a blood inlet, a blood outlet, a sweep gas inlet,
and a sweep gas outlet;
a hollow membrane ?ber array disposed within an interior
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interior of the hollow ?ber membrane array; and
another pneumatic pump provided in an atrium disposed at
the blood inlet.
9. The blood oxygenator of claim 8, further including an
atrium cyclical gas supply which maintains the atrium at an
internal pressure of up to zero.
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